Mirvie
PrivateLast Round
Series C
Sep 11, 2025
Est. Valuation
$155M
Total Funding Raised
$124.6M
Company Overview
Mirvie is a biotechnology company that provides a medical diagnostic platform aimed at enhancing pregnancy safety through predictive tests and therapeutic solutions for effective pregnancy management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirvie Comparables
Compare Mirvie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sera Prognostics Inc. | 77% | |
| Trinity Biotech plc | 77% | |
| NX Prenatal Inc. | 76% | |
Mirvie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 11, 2025 | ||||
| Series C | Aug 1, 2025 | ||||
| Grant | Aug 2, 2023 | ||||
| Debt | May 17, 2022 | ||||
| Series B | May 17, 2022 | ||||
Series A | Apr 27, 2021 |
Key People
Founding team and executive leadership
Mirvie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B |
| Khosla Ventures | Series B, Series A |
| Portfolia | Series C |
| Gates Foundation | Grant |
| General Catalyst | Series B |
| Foresite Capital | Series B |
| The Bill & Melinda Gates Foundation Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2025
$30M Series C round completed.
- May 14, 2025
Launched Encompass, a preeclampsia risk prediction and prevention tool.
Mirvie Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mirvie's valuation, stock price, and market status.